Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News
Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) | Morningstar
Vaccine maker stocks fall as Trump chooses RFK Jr. to lead HHS
What is HC Wainwright's Estimate for Novavax Q3 Earnings?
Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study Data - November 14, 2024 - Zacks.com
Health Care Down as Vaccine Makers Slide — Health Care Roundup | Morningstar
Novavax (NASDAQ:NVAX) Posts Earnings Results, Beats Expectations By $0.11 EPS
Novavax, Inc. (NASDAQ:NVAX) Q3 2024 Earnings Call Transcript
Novavax Inc (NVAX) Q3 2024 Earnings Call Highlights: Strategic Partnerships and Financial ...
Novavax's (NVAX) Buy Rating Reaffirmed at HC Wainwright
Novavax Cuts FY24 Revenue View Below Market; Stock Drops In Pre-market - Update
Novavax Inc. Q3 Loss Decreases, Beats Estimates
Novavax earnings beat by $0.07, revenue topped estimates By Investing.com
Novavax cuts 2024 revenue forecast again on lower COVID vaccine sales By Reuters
Novavax shares tumble 11% as revenue guidance disappoints By Investing.com
Novavax's stock slides 7% as guidance cut offsets narrower-than-expected third-quarter loss | Morningstar
NovaVax's stock slides 7% as lowered guidance offsets narrower-than-expected Q3 loss | Morningstar
Continuation of Trump Trade takes Dollar to multi-month highs - Newsquawk US Market Wrap
Novavax (NASDAQ:NVAX) Shares Gap Up - Should You Buy?
Novavax Target of Unusually High Options Trading (NASDAQ:NVAX)
Novavax to Move Forward With Covid-19-Flu Vaccine After FDA Lifts Clinical Hold — Update | Morningstar
Novavax to Move Forward With Covid-19, Influenza Vaccine After FDA Lifts Clinical Hold | Morningstar
FDA Lifts Clinical Hold On Novavax COVID-19-Influenza Combo Vaccine Candidate; Stock Up
Novavax’s Clinical Hold on Covid, Flu Combo Trial Cleared by FDA
U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial | Morningstar
FDA Lifts Hold on Novavax's Combo COVID-Flu Shot
Novavax stock soars as FDA removes clinical hold on its COVID and influenza shot By Investing.com
Novavax to Report Q3 Earnings: Here's What to Expect - November 11, 2024 - Zacks.com
Will These 5 Biotech Stocks Surpass Q3 Earnings Forecasts? - November 11, 2024 - Zacks.com
Nisa Investment Advisors LLC Has $296,000 Position in Novavax, Inc. (NASDAQ:NVAX)
Novavax (NVAX) Scheduled to Post Quarterly Earnings on Tuesday
Vanguard Group Inc's Strategic Acquisition of Novavax Inc Shares
Novavax to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Operational Highlights on November 12, 2024 | Morningstar
Novavax, Inc. (NASDAQ:NVAX) Given Consensus Recommendation of “Hold” by Brokerages
Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Rating of "Hold" from Analysts
A Game-Changing Vaccine
Novavax (NVAX) Stock Dips While Market Gains: Key Facts - October 29, 2024 - Zacks.com
Sanofi (NASDAQ:SNY) Q3 2024 Earnings Call Transcript
Earnings call: Sanofi reports robust Q3 sales and raises 2024 EPS guidance By Investing.com
Novavax (NVAX) Registers a Bigger Fall Than the Market: Important Facts to Note - October 23, 2024 - Zacks.com
Q&A on the 2024-2025 COVID-19 Vaccines
Is Trending Stock Novavax, Inc. (NVAX) a Buy Now? - October 21, 2024 - Zacks.com
NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Novavax, Inc. and Encourages Investors to Contact the Firm | Morningstar
Vontobel Holding Ltd. Acquires 261,464 Shares of Novavax, Inc. (NASDAQ:NVAX)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX | Morningstar
Brokerages Set Novavax, Inc. (NASDAQ:NVAX) Target Price at $18.33
Novavax (NVAX) Advances While Market Declines: Some Information for Investors - October 17, 2024 - Zacks.com
Novavax Stock Falls After FDA Puts Two Vaccine Programs on Hold - October 17, 2024 - Zacks.com
3 Vaccine Stocks to Watch as Flu Season Approaches
Novavax (NASDAQ:NVAX) Price Target Lowered to $25.00 at Jefferies Financial Group
Novavax (NASDAQ:NVAX) Shares Gap Down - Time to Sell?
BofA cuts Novavax target on clinical trial delay By Investing.com